Screening for PKU heterozygosity in bipolar affectively ill patients

Area of Science:

• Biochemistry
• Psychiatry
• Genetics

Background:

• Phenylketonuria (PKU) is an inherited metabolic disorder.
• Altered amino acid metabolism, specifically phenylalanine and tyrosine, is investigated in psychiatric conditions.
• Heterozygous expression of metabolic disorders may contribute to complex diseases.

Purpose of the Study:

• To investigate plasma phenylalanine and tyrosine levels in bipolar disorder patients.
• To determine if reduced liver phenylalanine hydroxylase activity (PKU heterozygosity) is linked to affective disorders.
• To assess the utility of L-phenylalanine loading tests in identifying metabolic variations in psychiatric populations.

Main Methods:

• Administered an L-phenylalanine loading test to bipolar manic-depressive patients and normal controls.
• Measured plasma phenylalanine and tyrosine concentrations post-loading.
• Compared biochemical profiles between patient groups and controls.

Main Results:

• No significant differences in plasma phenylalanine or tyrosine were observed between bipolar patients and controls.
• The L-phenylalanine loading test successfully differentiated known PKU heterozygotes from other participants.
• This indicates the test's sensitivity to specific metabolic genotypes.

Conclusions:

• Plasma amino acid levels following L-phenylalanine loading do not appear to differentiate bipolar disorder patients from controls.
• The study supports the role of the L-phenylalanine loading test in identifying phenylketonuria heterozygotes.
• Further research into other heterozygous metabolic states is warranted to explore their potential role in psychiatric disorders.